Global Health (MEDANTA.NS) Stock Price

Global Health Price

NSE·CLOSED
1,268.00
​
Market closed

Over the last 5 years Global Health grew revenue by 19.7% annually, reaching 36.92 B INR. Earnings per share have grown at 67.6% per year over the last 5 years. For Global Health, the net margin of 13.0% is up versus 2.0% a few years ago. At today's price the dividend yield works out to roughly 0.04%. The payout ratio is around 3% of earnings. The consensus 12-month price target for Global Health is 1,369.35 INR, about 8.0% above where the stock trades today. Of 17 analysts, 11 rate the stock a buy — an overall Buy consensus.

Global Health stock price

Access this data via the Eulerpool API

Global Health business model & stock analysis

Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi and currently employs 9,350 full-time employees. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.

Frequently asked questions about Global Health

Analysts currently set an average price target of 1,418.21 INR for the Global Health stock (median: 1,369.35 INR), implying +11.8 % versus the latest price. The consensus is based on 17 analyst ratings.

17 analysts currently rate the Global Health stock: 11 recommend buying, 5 holding and 1 selling. For 2026, analysts expect Global Health to generate revenue of 43.76 B INR and earnings per share of 20.34 INR.

Converted at the current exchange rate, the Global Health share trades at 11.71 EUR (1,268.00 INR).

The Global Health share (MEDANTA.NS) is listed on 2 stock exchanges, including: NSE (Indien) (MEDANTA.NS).

The expected revenue of Global Health is 43.76 B INR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Global Health is 5.46 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Global Health is currently 62.35. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Global Health stock.

The price-to-sales ratio (P/S) of Global Health is currently 7.78. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Global Health stock.

The Eulerpool Quality Score for Global Health is 5/10.

The ISIN of Global Health is INE474Q01031. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Global Health is MEDANTA.NS. The ticker symbol is used to trade Global Health shares on the stock exchange.

Fair ValueTerminal
1,242.64 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
3.95 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website medanta.org
Country
Currency
INR
Initial public offering
Nov 16, 2022
ISIN
INE474Q01031
Cusip
Y2R1K6136
Market capitalization
340.59 B INRMega Cap
52-Week Range
PEG
5.91
P/E ratio
P/Ee 2026
62.35
P/Ee 2027
47.63
P/Ee 2028
38.09
P/Ee 2029
32.30
P/Ee 2030
35.41
P/S
P/Se
7.78
EV/EBIT
50.11
P/B Ratio
10.06
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
11.73 %
Dividend
Dividend yield
0.04 %
Est. Dividend Yield
0.04 %
Payout Ratio
2.79 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
1 year
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
20.00 %
Last updated Oct 8, 2026, 7:30 PM

Global Health Peer Group

Global Health Ticker

BSE · MEDANTA.BONSE INDIA · MEDANTA.NS

Global Health FIGI

MEDANTA:IN · BBG004M1ZW23MEDANTA:IB · BBG01B6TW785MEDANTA:IS · BBG01B6TW7B1